Rapid detection, cloning and molecular cytogenetic characterisation of sequences from an MRP-encoding amplicon by chromosome microdissection

M. E. Ray, X. Y. Guan, M. L. Slovak, J. M. Trent, P. S. Meltzer

Research output: Contribution to journalArticle

Abstract

Chromosome microdissection was utilised for the analysis of cytogenetic markers of gene amplification [homogeneously staining regions (hsrs) and double minutes (dmins)] in two doxorubicin-resistant cell lines, fibrosarcoma HT1080/DR4 and small-cell lung cancer H69AR. Microdissection products from the hsr(7)(pl2pl5) of HT1080/DR4 were amplified and used for fluorescent in situ hybridisation (micro-FISH) analysis of drug-sensitive HT1080, resistant HT1080/DR4 and normal lymphocytes. The results demonstrated that the hsr contains a domain of DNA amplification of complex origin including sequences derived from 16p11.2-16pl3.1, 2g11.2, 7q32-7q34 and 10q22. The amplification was confirmed by converting the microdissected probe into a microclone library for probing HT1080 and HT1080/DR4 Southerns. A micro-FISH probe from normal band region l6p11-16p13 further demonstrated amplification of 16p sequences in both HT1080/DR4 and H69AR. During the course of this analysis, Cole et al. (1992) (Science, 258, 1650-1653) published the amplification of the MRP gene in H69AR cells, which maps to chromosome 16p13.1. Our results corroborate the finding of MRP amplification in these doxorubicin-resistant cell lines, but, importantly, they provide information on the composition of the complex amplicon contributions from four different chromosomes. This study demonstrates the potential utility of chromosome microdissection for the rapid recovery of sequences from amplified regions in drug-resistant cells.

Original languageEnglish (US)
Pages (from-to)85-90
Number of pages6
JournalBritish Journal of Cancer
Volume70
Issue number1
StatePublished - Jul 1994
Externally publishedYes

Fingerprint

Microdissection
Molecular Cloning
Cytogenetics
Chromosomes
Gene Amplification
Staining and Labeling
Doxorubicin
Cell Line
Fibrosarcoma
Cytogenetic Analysis
Small Cell Lung Carcinoma
Fluorescence In Situ Hybridization
Pharmaceutical Preparations
Libraries
Lymphocytes
DNA

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Rapid detection, cloning and molecular cytogenetic characterisation of sequences from an MRP-encoding amplicon by chromosome microdissection. / Ray, M. E.; Guan, X. Y.; Slovak, M. L.; Trent, J. M.; Meltzer, P. S.

In: British Journal of Cancer, Vol. 70, No. 1, 07.1994, p. 85-90.

Research output: Contribution to journalArticle

Ray, M. E. ; Guan, X. Y. ; Slovak, M. L. ; Trent, J. M. ; Meltzer, P. S. / Rapid detection, cloning and molecular cytogenetic characterisation of sequences from an MRP-encoding amplicon by chromosome microdissection. In: British Journal of Cancer. 1994 ; Vol. 70, No. 1. pp. 85-90.
@article{14185fba27414abb856b1df0dc91ac98,
title = "Rapid detection, cloning and molecular cytogenetic characterisation of sequences from an MRP-encoding amplicon by chromosome microdissection",
abstract = "Chromosome microdissection was utilised for the analysis of cytogenetic markers of gene amplification [homogeneously staining regions (hsrs) and double minutes (dmins)] in two doxorubicin-resistant cell lines, fibrosarcoma HT1080/DR4 and small-cell lung cancer H69AR. Microdissection products from the hsr(7)(pl2pl5) of HT1080/DR4 were amplified and used for fluorescent in situ hybridisation (micro-FISH) analysis of drug-sensitive HT1080, resistant HT1080/DR4 and normal lymphocytes. The results demonstrated that the hsr contains a domain of DNA amplification of complex origin including sequences derived from 16p11.2-16pl3.1, 2g11.2, 7q32-7q34 and 10q22. The amplification was confirmed by converting the microdissected probe into a microclone library for probing HT1080 and HT1080/DR4 Southerns. A micro-FISH probe from normal band region l6p11-16p13 further demonstrated amplification of 16p sequences in both HT1080/DR4 and H69AR. During the course of this analysis, Cole et al. (1992) (Science, 258, 1650-1653) published the amplification of the MRP gene in H69AR cells, which maps to chromosome 16p13.1. Our results corroborate the finding of MRP amplification in these doxorubicin-resistant cell lines, but, importantly, they provide information on the composition of the complex amplicon contributions from four different chromosomes. This study demonstrates the potential utility of chromosome microdissection for the rapid recovery of sequences from amplified regions in drug-resistant cells.",
author = "Ray, {M. E.} and Guan, {X. Y.} and Slovak, {M. L.} and Trent, {J. M.} and Meltzer, {P. S.}",
year = "1994",
month = "7",
language = "English (US)",
volume = "70",
pages = "85--90",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Rapid detection, cloning and molecular cytogenetic characterisation of sequences from an MRP-encoding amplicon by chromosome microdissection

AU - Ray, M. E.

AU - Guan, X. Y.

AU - Slovak, M. L.

AU - Trent, J. M.

AU - Meltzer, P. S.

PY - 1994/7

Y1 - 1994/7

N2 - Chromosome microdissection was utilised for the analysis of cytogenetic markers of gene amplification [homogeneously staining regions (hsrs) and double minutes (dmins)] in two doxorubicin-resistant cell lines, fibrosarcoma HT1080/DR4 and small-cell lung cancer H69AR. Microdissection products from the hsr(7)(pl2pl5) of HT1080/DR4 were amplified and used for fluorescent in situ hybridisation (micro-FISH) analysis of drug-sensitive HT1080, resistant HT1080/DR4 and normal lymphocytes. The results demonstrated that the hsr contains a domain of DNA amplification of complex origin including sequences derived from 16p11.2-16pl3.1, 2g11.2, 7q32-7q34 and 10q22. The amplification was confirmed by converting the microdissected probe into a microclone library for probing HT1080 and HT1080/DR4 Southerns. A micro-FISH probe from normal band region l6p11-16p13 further demonstrated amplification of 16p sequences in both HT1080/DR4 and H69AR. During the course of this analysis, Cole et al. (1992) (Science, 258, 1650-1653) published the amplification of the MRP gene in H69AR cells, which maps to chromosome 16p13.1. Our results corroborate the finding of MRP amplification in these doxorubicin-resistant cell lines, but, importantly, they provide information on the composition of the complex amplicon contributions from four different chromosomes. This study demonstrates the potential utility of chromosome microdissection for the rapid recovery of sequences from amplified regions in drug-resistant cells.

AB - Chromosome microdissection was utilised for the analysis of cytogenetic markers of gene amplification [homogeneously staining regions (hsrs) and double minutes (dmins)] in two doxorubicin-resistant cell lines, fibrosarcoma HT1080/DR4 and small-cell lung cancer H69AR. Microdissection products from the hsr(7)(pl2pl5) of HT1080/DR4 were amplified and used for fluorescent in situ hybridisation (micro-FISH) analysis of drug-sensitive HT1080, resistant HT1080/DR4 and normal lymphocytes. The results demonstrated that the hsr contains a domain of DNA amplification of complex origin including sequences derived from 16p11.2-16pl3.1, 2g11.2, 7q32-7q34 and 10q22. The amplification was confirmed by converting the microdissected probe into a microclone library for probing HT1080 and HT1080/DR4 Southerns. A micro-FISH probe from normal band region l6p11-16p13 further demonstrated amplification of 16p sequences in both HT1080/DR4 and H69AR. During the course of this analysis, Cole et al. (1992) (Science, 258, 1650-1653) published the amplification of the MRP gene in H69AR cells, which maps to chromosome 16p13.1. Our results corroborate the finding of MRP amplification in these doxorubicin-resistant cell lines, but, importantly, they provide information on the composition of the complex amplicon contributions from four different chromosomes. This study demonstrates the potential utility of chromosome microdissection for the rapid recovery of sequences from amplified regions in drug-resistant cells.

UR - http://www.scopus.com/inward/record.url?scp=0028180832&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028180832&partnerID=8YFLogxK

M3 - Article

C2 - 8018546

AN - SCOPUS:0028180832

VL - 70

SP - 85

EP - 90

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 1

ER -